Late Renal Graft Failure: Immunosuppression Study

We are comparing the effects of continuing versus stopping immunosuppression in patients with late renal graft failure. This study aims to see how these approaches impact health outcomes over two years.

>2 yearsMonitoring phase (IV)No PlaceboInvestigational MedicinesOralInternal MedicineNephrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Adoport
Adoport is a medicine used to help prevent the body from rejecting a transplanted organ.
Advagraf
Advagraf is a medicine used to prevent organ rejection in people who have received a kidney, liver, or heart transplant.
Envarsus
Envarsus is a medicine used to help prevent the body from rejecting a transplanted kidney.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Ciclosporin
Ciclosporin is a substance that suppresses the immune system to prevent organ transplant rejection and treat autoimmune conditions.
Tacrolimus
Tacrolimus is a substance that suppresses the immune system to prevent organ transplant rejection and treat certain inflammatory conditions like severe eczema.
Tacrolimus Monohydrate
Tacrolimus monohydrate is a substance that suppresses the immune system to prevent organ transplant rejection and treat severe inflammatory skin conditions.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Conferoport

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Adport
Adport
Adport

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Germans Trias I Pujol
Nephrology
Badalona, Spain
Hospital Del Mar
Nephrology
Barcelona, Spain
Hospital Universitari Vall D Hebron
Nephrology
Barcelona, Spain
Sponsor: Vall D'hebron Institut De Recerca
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.